Pharmagen ApS: Financial statements 2024
CVR: 36687193
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
Pharmagen ApS (CVR 36687193) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -14,201 and a net result of DKK -19,304 compared with DKK 15,308 the year before. Equity in the 2024 report amounted to DKK -311,164.
- Gross Profit
- DKK -14,201
- Profit/Loss
- DKK -19,304
- Equity
- DKK -311,164
- Total Assets
- DKK 932,642
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -14 t. | -19 t. | -311 t. | 0 |
| 2023 | - | -10 t. | 15 t. | -292 t. | 0 |
| 2022 | - | 8 t. | -242 t. | -307 t. | - |
| 2021 | - | 337 t. | 383 t. | -65 t. | - |
| 2020 | - | 373 t. | 76 t. | -448 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Pharmagen ApS
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.